|
|
Atherosclerosis is the buildup of plaque on the inside walls of arteries. Plaque is made up of
low density lipoprotein (LDL), macrophages, smooth muscle cells, platelets, and other substances.
It may narrow the lumen of a blood vessel and restrict blood flow. Plaque
rupture can induce the formation of thrombus (blood clot) and block blood
flow. This will result in ischemic stroke or heart attack.
Formation of foam cells
The first stage in the development of atherosclerosis is the formation of
foam cells (macrophages with ingested oxidized LDL). The process
begins with trap of LDL in the intima, which lies just below the
endothelium (the monolayer of cells lining the arterial wall). Trapped LDL could
be oxidized, triggering recruitment of monocytes into the intima.
Several adhesion molecules are involved, including vascular-cell adhesion
molecule (VCAM), integrin, selectin, and others. After entering the intima, monocytes
differentiate into macrophages and ingest oxidized LDL.
Formation of plaque
As atherosclerosis progresses, T lymphocytes, platelets and smooth muscle
cells also join foam cells, expanding the plaque size. This involves
cytokines to activate T lymphocytes and growth factors to promote proliferation
of smooth muscle cells. Platelets can also release cytokines and growth
factors to enhance migration and proliferation of smooth muscle cells.
During this stage, a fibrous cap is formed to separate the plaque from the
lumen.
Thrombosis
Thrombosis (formation of thrombus) arises from plaque
rupture. Macrophages may release metalloproteinases and other proteolytic
enzymes to degrade fibrous cap, making it susceptible to rupture. Plaque rupture
activates platelets, leading to formation of blood clots at the site of
lesion (mechanism from Internet Stroke Center).
How to say NO to atherosclerosis
Molecular mechanisms for the production of nitric oxide (NO) by exercise leading to
the protection of atherosclerosis.
Associated genes
APOA1
Encodes apolipoprotein A-I, which is the major protein component of high density
lipoprotein (HDL). Since HDL is less likely than LDL to enter the intima, high
level of HDL is generally good for your health.
APOB
Encodes apolipoprotein B, which is the major protein component of LDL.
APOC2
Encodes a protein component of very low density lipoprotein (VLDL).
ABCA1
Encodes an ATP-binding cassette (ABC) transporter, which is involved in
clearing excess cholesterol and generating HDL.
CCL2
Encodes the cytokine MCP-1 that has chemotactic activity for monocytes.
CETP
Encodes cholestery ester transfer protein. A deficiency of CETP is associated
with increased HDL levels and decreased LDL levels (review).
CX3CR1
Encodes a chemokine receptor involved in cell adhesion (reference).
MMP9
Encodes a matrix metalloproteinase, which is involved in plaque rupture (review,
polymorphism).
OLR1
Encodes oxidized LDL receptor.
Free Online Textbook:
Inflammatory
Atherosclerosis - Richard Frink, 2002.
Review articles:
HDL/LDL
- New
Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol
Transport - Circulation Research, 2005.
- Antiinflammatory
Properties of HDL - Circulation Research, 2004.
- Molecular
Interactions Leading to Lipoprotein Retention and the Initiation of
Atherosclerosis - Arterio., Throm. and Vascu. Bio., 2004.
- A review of
CETP and its relation to atherosclerosis - J. Lipid Research, 2004.
- The role of
oxidized phospholipids and HDL - J. Lipid Research, 2004.
- Genetics of
LDL particle heterogeneity - J. Lipid Research, 2004.
- Endothelial
Protection by High-Density Lipoproteins - Arterio., Throm. and Vascu. Bio., 2003.
- Influence
of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis
- Arterio., Throm. and Vascu. Bio., 2003.
- High
Density Lipoproteins and Arteriosclerosis - Arterio., Throm. and Vascu. Bio., 2001.
Blood
- Platelets
and Chemokines in Atherosclerosis - Circulation Research, 2005.
- Tissue
Factor–Factor VIIa Signaling - Arterio., Throm. and Vascu. Bio.,
2005.
- Thrombin
and Phenotypic Modulation of the Endothelium - Arterio., Throm. and
Vascu. Bio., 2004.
- Genetic
Determinants of Arterial Thrombosis - Arterio., Throm. and Vascu. Bio., 2003.
- Platelets and Thrombin Generation - Arterio.,
Throm. and Vascu. Bio., 2002.
- Factor V: a combination of Dr Jekyll and Mr Hyde - Blood, 2003.
- Role of
factor XIII in fibrin clot formation - Blood, 2002.
- Elevated
Factor VIII Levels and the Risk of Thrombosis - Arterio., Throm. and
Vascu. Bio., 2001
Immune System
- Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways - Physiol. Rev., 2006.
- Immune function in atherogenesis - J. Lipid Research, 2005.
- Chemokines:
Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic
Vascular Disease - Arterio., Throm. and Vascu. Bio., 2004.
- Potential
Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis - Arterio.,
Throm. and
Vascu. Bio., 2004.
- TLR
Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
- J. Immunol., 2004.
- Effects of
infection and inflammation on lipid and lipoprotein metabolism
mechanisms and consequences to the host - J. Lipid Research, 2004.
- Transforming
Growth Factor ß and Atherosclerosis: So Far, So Good for the Protective
Cytokine Hypothesis - Arterio., Throm. and Vascu. Bio., 2003.
- Interleukins
in Atherosclerosis: Molecular Pathways and Therapeutic Potential - Pharm.
Review, 2003.
- Immune
Mechanisms in Atherosclerosis - Arterio., Throm. and Vascu. Bio., 2001.
- Inflammation
and Atherosclerosis - Circulation, 2002
- Innate
and Adaptive Immunity in the Pathogenesis of Atherosclerosis - Circu.
Res., 2002.
Oxidative Stress
Miscellaneous
- Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology - Arterio., Throm. and Vascu. Bio.,
2005.
- Adrenomedullin:
A Protective Factor for Blood Vessels - Arterio., Throm. and Vascu. Bio., 2005.
- Mechanisms,
Pathophysiology, and Therapy of Arterial Stiffness - Arterio., Throm. and Vascu. Bio.,
2005.
- Nuclear
Factor kB Signaling in Atherogenesis - Arterio., Throm. and Vascu. Bio.,
2005.
- Identifying Novel Genes for Atherosclerosis through Mouse-Human Comparative Genetics
- Am. J. Hum. Genetics, 2005.
- Dual
Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and
Atherosclerotic Plaque Rupture - Physiol. Rev., 2005.
- Role
of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis
- Arterio., Throm. and Vascu. Bio., 2005.
- Lysosomal
Cysteine Proteases in Atherosclerosis - Arterio., Throm. and Vascu. Bio., 2004.
- PPAR- and
LXR-dependent pathways controlling lipid metabolism and the development
of atherosclerosis - J. Lipid Research, 2004.
- Toward a
biological network for atherosclerosis - J. Lipid Research, 2004.
- Site
Specificity of Atherosclerosis - Arterio., Throm. and Vascu.
Bio., 2003.
- Role
of Monocytes in Atherogenesis - Physiol. Rev., 2003.
- PPARs in
atherosclerosis - J. Clin. Investi., 2004.
- Flow-dependent
regulation of endothelial nitric oxide synthase: role of protein kinases
- Am. J. Physiol., 2003.
- Efflux and
Atherosclerosis: ABCA1 Gene - Arterio., Throm. and Vascu.
Bio., 2003.
|